Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer.

Noor A LokmanRachel HoKavyadharshini GunasegaranWendy M BonnerMartin K OehlerCarmela Ricciardelli

Published in: Journal of experimental & clinical cancer research : CR (2019)

These findings suggest that ATRA inhibits serous ovarian cancer proliferation and invasion via both S100A10 dependant and S100A10 independent mechanisms. Our results show that ATRA has promising potential as a novel therapy against serous ovarian cancer that warrants further evaluation.

Keyphrases

high grade
stem cells
risk assessment
human health
climate change
chemotherapy induced